Search Results

There are 12160 results for: content related to: The acute effects of L -theanine in comparison with alprazolam on anticipatory anxiety in humans

  1. Alprazolam for depression

    Intervention Review

    The Cochrane Library

    Harm van Marwijk, Gideon Allick, Froukje Wegman, Arjan Bax and Ingrid I Riphagen

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD007139.pub2

  2. You have free access to this content
    Clinical Pharmacology, Clinical Efficacy, and Behavioral Toxicity of Alprazolam: A Review of the Literature

    CNS Drug Reviews

    Volume 10, Issue 1, March 2004, Pages: 45–76, Joris C. Verster and Edmund R. Volkerts

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2004.tb00003.x

  3. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study

    Acta Psychiatrica Scandinavica

    Volume 83, Issue S365, July 1991, Pages: 18–27, S. Andersch, N. K. Rosenberg, H. Kullingsjö, J.-O. Ottosson, P. Bech, J. Bruun-Nansen, L. Hanson, K. Lorentzen, M. Mellergård, S. Rasmussen and R. Rosenberg

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1991.tb03097.x

  4. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study

    Acta Psychiatrica Scandinavica

    Volume 88, Issue 1, July 1993, Pages: 1–11, D. V. Sheehan, A. B. Raj, K. Harnett-Sheehan, S. Soto and E. Knapp

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1993.tb03405.x

  5. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome

    Acta Psychiatrica Scandinavica

    Volume 82, Issue 5, November 1990, Pages: 359–365, M. Albus, Y. Lecrubier, W. Maier, R. Buller, R. Rosenberg and H. Hippius

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1990.tb01401.x

  6. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder

    Depression and Anxiety

    Volume 25, Issue 8, August 2008, Pages: E18–E26, E.H. Uhlenhuth, Vladan Starcevic, Clifford Qualls, Edward J. Antal, William Matuzas, Javaid I. Javaid and Jamie Barnhill

    Version of Record online : 25 OCT 2007, DOI: 10.1002/da.20403

  7. Characteristics of Alprazolam-Related Deaths Compiled by a Centralized State Medical Examiner

    The American Journal on Addictions

    Volume 21, Issue s1, November 2012, Pages: S27–S34, Neel A. Shah, Marie A. Abate, Michael J. Smith, James A. Kaplan, James C. Kraner and David J. Clay

    Version of Record online : 16 NOV 2012, DOI: 10.1111/j.1521-0391.2012.00298.x

  8. Alprazolam: Review of pharmacological, pharmacokinetic, and clinical data

    Drug Development Research

    Volume 6, Issue 1, 1985, Pages: 1–12, Philip F. VonVoigtlander and Robert N. Straw

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430060102

  9. Specific effects of benzodiazepines and tricyclic antidepressants in panic disorder: comparisons of clomipramine with alprazolam SR and adinazolam SR

    Human Psychopharmacology: Clinical and Experimental

    Volume 14, Issue 2, March 1999, Pages: 119–124, Robert L. Holland, Bruno C. Musch and Ian Hindmarch

    Version of Record online : 9 MAR 1999, DOI: 10.1002/(SICI)1099-1077(199903)14:2<119::AID-HUP77>3.0.CO;2-1

  10. Alprazolam: Pharmacokinetics, Clinical Efficacy, and Mechanism of Action

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 2, Issue 5, September-October 1982, Pages: 243–253, Jan A. Fawcett and Howard M. Kravitz

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1982.tb03191.x

  11. Alprazolam absorption kinetics affects abuse liability

    Clinical Pharmacology & Therapeutics

    Volume 57, Issue 3, March 1995, Pages: 356–365, Geoffrey K. Mumford, Suzette M. Evans, Joseph C. Fleishaker and Roland R. Griffiths

    Version of Record online : 26 MAR 1995, DOI: 10.1016/0009-9236(95)90162-0

  12. Drug Treatment of Panic Disorder

    Pharmacology & Toxicology

    Volume 72, Issue 6, June 1993, Pages: 344–353, Raben Rosenberg

    Version of Record online : 25 MAR 2009, DOI: 10.1111/j.1600-0773.1993.tb01343.x

  13. Alprazolam-ritonavir interaction: Implications for product labeling

    Clinical Pharmacology & Therapeutics

    Volume 67, Issue 4, April 2000, Pages: 335–341, David J. Greenblatt, Lisa L. von Moltke, Jerold S. Harmatz, Anna Liza B. Durol, Johanna P. Daily, Jennifer A. Graf, Polyxane Mertzanis, Jonathan L. Hoffman and Richard I. Shader

    Version of Record online : 11 APR 2000, DOI: 10.1067/mcp.2000.105757

  14. Alprazolam for essential tremor

    Intervention Review

    The Cochrane Library

    Elisa Bruno, Alessandra Nicoletti, Graziella Quattrocchi, Graziella Filippini, Mario Zappia and Carlo Colosimo

    Published Online : 6 DEC 2015, DOI: 10.1002/14651858.CD009681.pub2

  15. Kinetics and Dynamics of Intravenous Adinazolam, N-Desmethyl Adinazolam, and Alprazolam in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 529–537, Karthik Venkatakrishnan, Kerry E. Culm, Bruce L. Ehrenberg, Jerold S. Harmatz, Kathleen E. Corbett, Joseph C. Fleishaker and David J. Greenblatt

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004269105

  16. Selegiline Transdermal System: An Examination of the Potential for CYP450-Dependent Pharmacokinetic Interactions With 3 Psychotropic Medications

    The Journal of Clinical Pharmacology

    Volume 47, Issue 2, February 2007, Pages: 146–158, Dr Albert J. Azzaro, Dr John Ziemniak, Ms Eva Kemper, Dr Bryan J. Campbell and Dr Chad VanDenBerg

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006296151

  17. Benzodiazepine Receptor Binding of Triazolobenzodiazepines In Vivo: Increased Receptor Number with Low-Dose Alprazolam

    Journal of Neurochemistry

    Volume 49, Issue 5, November 1987, Pages: 1595–1601, Lawrence G. Miller, David J. Greenblatt, Jamie G. Barnhill, Stephen I. Deutsch, Richard I. Shader and Steven M. Paul

    Version of Record online : 5 OCT 2006, DOI: 10.1111/j.1471-4159.1987.tb01032.x

  18. Effect of alprazolam on anxiety and cardiomyopathy induced by doxorubicin in mice

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 3, June 2012, Pages: 356–362, Md Jamir Anwar, Krishna K. Pillai, Razia Khanam, Mohammad Akhtar and Divya Vohora

    Version of Record online : 24 FEB 2011, DOI: 10.1111/j.1472-8206.2011.00925.x

  19. A Study of Pharmacokinetic Interaction Between Buspirone and Alprazolam at Steady State

    The Journal of Clinical Pharmacology

    Volume 33, Issue 11, November 1993, Pages: 1104–1109, A. B. Buch, D. R. Van Harken, R. J. Seidehamel and R. H. Barbhaiya

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1993.tb01947.x

  20. Pharmacokinetics and physiologic effects of alprazolam after a single oral dose in healthy mares

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 38, Issue 3, June 2015, Pages: 301–304, D. M. Wong, J. L. Davis, C. J. Alcott, K. L. Hepworth-Warren, N. L. Galow-Kersh, S. Rice and J. F. Coetzee

    Version of Record online : 27 NOV 2014, DOI: 10.1111/jvp.12192